drugset / Trial / NCT01541943
Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of HL-040XC in patients with essential hypertension and hyperlipidemia
Timeline
- Start
- 2012-03
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | — | Oral |
| Subject | HL040XC | Unknown | — | Oral |
| Comparator | Losartan | Other / unclassified | — | Oral |